Doxepin 3 MG Oral Tablet — RxCUI 966787
RxNorm drug concept · Semantic clinical drug
RxCUI 966787
Semantic clinical drug · SCD
● Current RxNorm concept 29 FDA products
67 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI966787
Official nameDoxepin 3 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdoxepin 3 MG (as doxepin hydrochloride 3.39 MG) Oral Tablet
FDA products mapped29
Package NDCs mapped67
Reported Medicaid activity (SDUD)27,184 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Doxepin Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You're right that doxepin is also used as an antidepressant in pill form, but this cream version is completely different — it's applied to the skin specifically to relieve moderate...
- What exactly is this cream for? My doctor said it's for itching but it's usually an antidepressant — that seems strange.
- That's one of the most important things to know about this cream. Doxepin is absorbed through your skin into your bloodstream, and it can reach levels high enough to cause real dro...
- Why does the cream make me so sleepy? I didn't expect that from something I'm putting on my skin.
🕸️ Concept Web — How Doxepin 3 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Doxepin 3 MG Oral Tablet
RxCUI 966787 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Doxepin
3638IN
-
Doxepin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Silenor
966788BN
-
Silenor
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Doxepin Oral Tablet
375040SCDF -
Doxepin Oral Product
1160768SCDG -
Doxepin Pill
1160769SCDG -
Doxepin Oral Tablet [Silenor]
966790SBDF -
Silenor Oral Product
1181995SBDG -
Silenor Pill
1182604SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Doxepin Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Doxepin 3 MG
966786SCDC -
Doxepin 3 MG Oral Tablet [Silenor]
966791SBD -
Doxepin 3 MG [Silenor]
966789SBDC
-
Doxepin 3 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Doxepin 3 MG
SCDC · 966786 -
Doxepin Oral Tablet
SCDF · 375040 -
Doxepin Oral Product
SCDG · 1160768 -
Doxepin Pill
SCDG · 1160769
Brand-Name Concepts
-
Doxepin 3 MG Oral Tablet [Silenor]
SBD · 966791 -
Doxepin 3 MG [Silenor]
SBDC · 966789 -
Doxepin Oral Tablet [Silenor]
SBDF · 966790 -
Silenor Oral Product
SBDG · 1181995 -
Silenor Pill
SBDG · 1182604 -
Silenor
BN · 966788
📦 FDA Products & Package NDCs
29 products · 67 package NDCs
67 package NDCs map to RxCUI 966787 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00228-3315-03 | 30 TABLET, FILM COATED in 1 BOTTLE (0228-3315-03) | Doxepin | Actavis Pharma, Inc. | 2020-01-02 |
| 00228-3316-03 | 30 TABLET, FILM COATED in 1 BOTTLE (0228-3316-03) | Doxepin | Actavis Pharma, Inc. | 2020-01-02 |
| 10135-0758-30 | 30 TABLET, FILM COATED in 1 BOTTLE (10135-758-30) | Doxepin | Marlex Pharmaceuticals, Inc. | 2023-10-01 |
| 10135-0764-30 | 30 TABLET, FILM COATED in 1 BOTTLE (10135-764-30) | Doxepin | Marlex Pharmaceuticals, Inc. | 2023-10-01 |
| 27241-0280-30 | 30 TABLET in 1 BOTTLE (27241-280-30) | Doxepin | Ajanta Pharma USA Inc. | 2024-07-01 |
| 27241-0281-30 | 30 TABLET in 1 BOTTLE (27241-281-30) | Doxepin | Ajanta Pharma USA Inc. | 2024-07-01 |
| 42847-0103-03 | 30 TABLET in 1 BLISTER PACK (42847-103-03) | Silenor | Currax Pharmaceuticals LLC | 2010-08-01 |
| 42847-0103-10 | 100 TABLET in 1 BOTTLE (42847-103-10) | Silenor | Currax Pharmaceuticals LLC | 2010-08-01 |
| 42847-0103-30 | 30 TABLET in 1 BOTTLE (42847-103-30) | Silenor | Currax Pharmaceuticals LLC | 2010-08-01 |
| 42847-0103-50 | 500 TABLET in 1 BOTTLE (42847-103-50) | Silenor | Currax Pharmaceuticals LLC | 2010-08-01 |
| 42847-0106-03 | 30 TABLET in 1 BLISTER PACK (42847-106-03) | Silenor | Currax Pharmaceuticals LLC | 2010-08-01 |
| 42847-0106-10 | 100 TABLET in 1 BOTTLE (42847-106-10) | Silenor | Currax Pharmaceuticals LLC | 2010-08-01 |
| 42847-0106-30 | 30 TABLET in 1 BOTTLE (42847-106-30) | Silenor | Currax Pharmaceuticals LLC | 2010-08-01 |
| 42847-0106-50 | 500 TABLET in 1 BOTTLE (42847-106-50) | Silenor | Currax Pharmaceuticals LLC | 2010-08-01 |
| 44183-0103-30 | 30 TABLET in 1 BOTTLE (44183-103-30) | doxepin hydrochloride | Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven | 2010-08-01 |
| 44183-0106-30 | 30 TABLET in 1 BOTTLE (44183-106-30) | doxepin hydrochloride | Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven | 2010-08-01 |
| 51407-0811-30 | 30 TABLET in 1 BOTTLE (51407-811-30) | Doxepin hydrochloride | Golden State Medical Supply, Inc. | 2023-05-31 |
| 51407-0812-30 | 30 TABLET in 1 BOTTLE (51407-812-30) | Doxepin hydrochloride | Golden State Medical Supply, Inc. | 2023-05-31 |
| 51672-4246-02 | 30 TABLET in 1 BOTTLE (51672-4246-2) | doxepin hydrochloride | Sun Pharmaceutical Industries, Inc. | 2025-08-07 |
| 51672-4247-02 | 30 TABLET in 1 BOTTLE (51672-4247-2) | doxepin hydrochloride | Sun Pharmaceutical Industries, Inc. | 2025-08-07 |
| 59651-0844-30 | 30 TABLET in 1 BOTTLE (59651-844-30) | DOXEPIN | Aurobindo Pharma Limited | 2025-07-12 |
| 59651-0845-30 | 30 TABLET in 1 BOTTLE (59651-845-30) | DOXEPIN | Aurobindo Pharma Limited | 2025-07-12 |
| 64380-0203-01 | 30 TABLET in 1 BOTTLE, PLASTIC (64380-203-01) | Doxepin | Strides Pharma Science Limited | 2022-09-12 |
| 64380-0203-02 | 100 TABLET in 1 BOTTLE, PLASTIC (64380-203-02) | Doxepin | Strides Pharma Science Limited | 2022-09-12 |
| 64380-0203-03 | 500 TABLET in 1 BOTTLE, PLASTIC (64380-203-03) | Doxepin | Strides Pharma Science Limited | 2022-09-12 |
| 64380-0204-01 | 30 TABLET in 1 BOTTLE, PLASTIC (64380-204-01) | Doxepin | Strides Pharma Science Limited | 2022-09-12 |
| 64380-0204-02 | 100 TABLET in 1 BOTTLE, PLASTIC (64380-204-02) | Doxepin | Strides Pharma Science Limited | 2022-09-12 |
| 64380-0204-03 | 500 TABLET in 1 BOTTLE, PLASTIC (64380-204-03) | Doxepin | Strides Pharma Science Limited | 2022-09-12 |
| 70771-1528-00 | 1000 TABLET in 1 BOTTLE (70771-1528-0) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1528-01 | 100 TABLET in 1 BOTTLE (70771-1528-1) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1528-03 | 30 TABLET in 1 BOTTLE (70771-1528-3) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1528-04 | 10 BLISTER PACK in 1 CARTON (70771-1528-4) / 10 TABLET in 1... | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1528-05 | 500 TABLET in 1 BOTTLE (70771-1528-5) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1528-09 | 90 TABLET in 1 BOTTLE (70771-1528-9) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1529-00 | 1000 TABLET in 1 BOTTLE (70771-1529-0) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1529-01 | 100 TABLET in 1 BOTTLE (70771-1529-1) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1529-03 | 30 TABLET in 1 BOTTLE (70771-1529-3) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1529-04 | 10 BLISTER PACK in 1 CARTON (70771-1529-4) / 10 TABLET in 1... | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1529-05 | 500 TABLET in 1 BOTTLE (70771-1529-5) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 70771-1529-09 | 90 TABLET in 1 BOTTLE (70771-1529-9) | doxepin | Zydus Lifesciences Limited | 2024-06-30 |
| 72162-2474-03 | 30 TABLET in 1 BOTTLE (72162-2474-3) | Doxepin | Bryant Ranch Prepack | 2025-05-01 |
| 72205-0052-05 | 500 TABLET in 1 BOTTLE (72205-052-05) | Doxepin hydrochloride | Novadoz Pharmaceuticals LLC | 2023-04-05 |
| 72205-0052-30 | 30 TABLET in 1 BOTTLE (72205-052-30) | Doxepin hydrochloride | Novadoz Pharmaceuticals LLC | 2023-04-05 |
| 72205-0052-91 | 100 TABLET in 1 BOTTLE (72205-052-91) | Doxepin hydrochloride | Novadoz Pharmaceuticals LLC | 2023-04-05 |
| 72205-0053-05 | 500 TABLET in 1 BOTTLE (72205-053-05) | Doxepin hydrochloride | Novadoz Pharmaceuticals LLC | 2023-04-05 |
| 72205-0053-30 | 30 TABLET in 1 BOTTLE (72205-053-30) | Doxepin hydrochloride | Novadoz Pharmaceuticals LLC | 2023-04-05 |
| 72205-0053-91 | 100 TABLET in 1 BOTTLE (72205-053-91) | Doxepin hydrochloride | Novadoz Pharmaceuticals LLC | 2023-04-05 |
| 72578-0181-01 | 100 TABLET in 1 BOTTLE (72578-181-01) | doxepin | Viona Pharmaceuticals Inc | 2024-06-30 |
| 72578-0181-05 | 500 TABLET in 1 BOTTLE (72578-181-05) | doxepin | Viona Pharmaceuticals Inc | 2024-06-30 |
| 72578-0181-06 | 30 TABLET in 1 BOTTLE (72578-181-06) | doxepin | Viona Pharmaceuticals Inc | 2024-06-30 |
Observed labelers:
Viona Pharmaceuticals Inc (12) ·
Zydus Lifesciences Limited (12) ·
Currax Pharmaceuticals LLC (8) ·
Archis Pharma LLC (6) ·
Novadoz Pharmaceuticals LLC (6) ·
Strides Pharma Science Limited (6)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.